- $22.41bn
- $21.91bn
- $606.42m
Focus: Drugmakers delay some European launches with a wary eye on Trump's pricing policies
U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM
U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
U.S. STOCKS ON THE MOVE-Insmed, United Therapeutics, CrowdStrike
Insmed climbs after Morgan Stanley upgrades to 'overweight,' hikes PT
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla
U.S. STOCKS ON THE MOVE-Energy firms, Cencora, Stryker
U.S. STOCKS ON THE MOVE-United Airlines, Synopsys, PG&E
Insmed rises as late‑stage trial backs wider use of lung disease drug
U.S. RESEARCH ROUNDUP- Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics
Brief: MHRA Says Licensed Brensocatib as First Drug for Non-Cystic Fibrosis Bronchiectasis in Patients Aged 12+
Insmed rises as quarterly revenue beats estimates
Brief: Insmed Reports Fourth-Quarter And Full-Year 2025 Financial Results And Provides Business Update
U.S. RESEARCH ROUNDUP- American Express Co, Ameriprise Financial, Mastercard
U.S. STOCKS ON THE MOVE-Intel, Gartner, Chipotle
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (updated)
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026